Posted by Michael Wonder on 15 Oct 2019
Flemish Alzheimerliga wants to maintain reimbursement of Alzheimer’s disease medication
14 October 2019 - The Flemish Alzheimerliga, that represents patients with Alzheimer’s disease and their families, is against the National Institute for Health and Disability Insurance’s idea to stop reimbursing Alzheimer’s medication.
Anyone that gets diagnosed with Alzheimer’s disease from 1 July 2020 may no longer be reimbursed by their health insurance fund for certain medicines against the disease.
The measure is part of the National Institute for Health and Disability Insurance’s (RIZIV) budget proposal for 2020.
